ASX - By Stock
|
ATH |
Re:
Ann: Notification of cessation of securities - ATH
|
|
RebekahChambers
|
23 |
3.3K |
2 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
23
|
3.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Notification of cessation of securities - ATH
|
|
RebekahChambers
|
23 |
3.3K |
4 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
23
|
3.3K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
RebekahChambers
|
11 |
3.0K |
5 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
11
|
3.0K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
RebekahChambers
|
11 |
3.0K |
9 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
11
|
3.0K
|
9
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
3 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
39
|
10K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
1 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
39
|
10K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
4 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
5 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
39
|
10K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
2 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
39
|
10K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
What to hopefully look forward too
|
|
RebekahChambers
|
39 |
10K |
4 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
RebekahChambers
|
73 |
16K |
2 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
73
|
16K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
RebekahChambers
|
73 |
16K |
3 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
73
|
16K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
RebekahChambers
|
73 |
16K |
3 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
73
|
16K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Meetings this year
|
|
RebekahChambers
|
10 |
2.3K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
10
|
2.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Meetings this year
|
|
RebekahChambers
|
10 |
2.3K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
10
|
2.3K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
RebekahChambers
|
168 |
47K |
7 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
168
|
47K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
RebekahChambers
|
168 |
47K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
168
|
47K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
RebekahChambers
|
168 |
47K |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
168
|
47K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
RebekahChambers
|
168 |
47K |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
168
|
47K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
RebekahChambers
|
75 |
23K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
75
|
23K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
RebekahChambers
|
75 |
23K |
8 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
75
|
23K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
RebekahChambers
|
75 |
23K |
4 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
75
|
23K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
3 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
79
|
21K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
3 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
79
|
21K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
79
|
21K
|
2
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
7 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
79
|
21K
|
7
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
4 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
79
|
21K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
79
|
21K
|
0
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
5 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
3 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
1 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
1
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
4 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
0
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
RebekahChambers
|
79 |
21K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
79
|
21K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
|
|
RebekahChambers
|
5 |
2.3K |
14 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
5
|
2.3K
|
14
|
|
ASX - By Stock
|
ATH |
Re:
News: ATH Alterity Therapeutics Seeks Trading Halt
|
|
RebekahChambers
|
18 |
6.0K |
9 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
18
|
6.0K
|
9
|
|
ASX - By Stock
|
TKL |
Re:
Ann: Additional REE targets identified at Mt Cattlin
|
|
RebekahChambers
|
7 |
2.4K |
2 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
7
|
2.4K
|
2
|
|
ASX - By Stock
|
TKL |
Re:
Ann: Additional REE targets identified at Mt Cattlin
|
|
RebekahChambers
|
7 |
2.4K |
3 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
7
|
2.4K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Pause in Trading
|
|
RebekahChambers
|
19 |
5.2K |
3 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
19
|
5.2K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Pause in Trading
|
|
RebekahChambers
|
19 |
5.2K |
5 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
19
|
5.2K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: US FDA Approval for IND Application for ATH434 for MSA
|
|
RebekahChambers
|
13 |
7.3K |
5 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
13
|
7.3K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: US FDA Approval for IND Application for ATH434 for MSA
|
|
RebekahChambers
|
13 |
7.3K |
6 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
13
|
7.3K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
NASDEC
|
|
RebekahChambers
|
3 |
1.0K |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
3
|
1.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
What's Happening Regarding Regaining Nasdaq Compliance?
|
|
RebekahChambers
|
8 |
2.5K |
5 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
8
|
2.5K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
What is happening with PBT2?
|
|
RebekahChambers
|
25 |
10K |
0 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
25
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4C and Quarterly Cash Flow Report
|
|
RebekahChambers
|
11 |
4.4K |
1 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
11
|
4.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
What is happening with PBT2?
|
|
RebekahChambers
|
25 |
10K |
5 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
25
|
10K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Investor Presentation
|
|
RebekahChambers
|
8 |
3.7K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
8
|
3.7K
|
1
|
|